Collegium Pharmaceutical Stock Forecast - Accumulation Distribution

COLL Stock  USD 30.71  0.48  1.54%   
Collegium Stock Forecast is based on your current time horizon. Although Collegium Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Collegium Pharmaceutical's systematic risk associated with finding meaningful patterns of Collegium Pharmaceutical fundamentals over time.
  
Fixed Asset Turnover is expected to rise to 27.04 this year, although the value of Inventory Turnover will most likely fall to 7.14. . The value of Common Stock Shares Outstanding is expected to slide to about 30.1 M. The value of Net Loss is expected to slide to about (30.2 M).

Open Interest Against 2024-12-20 Collegium Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Collegium Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Collegium Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Collegium Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Collegium Pharmaceutical's open interest, investors have to compare it to Collegium Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Collegium Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Collegium. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
On October 21, 2024 Collegium Pharmaceutical had Accumulation Distribution of 31426.5. The accumulation distribution (A/D) indicator shows the degree to which Collegium Pharmaceutical is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Collegium Pharmaceutical to determine if accumulation or reduction is taking place in the market. This value is adjusted by Collegium Pharmaceutical trading volume to give more weight to distributions with higher volume over lower volume.
Check Collegium Pharmaceutical VolatilityBacktest Collegium PharmaceuticalTrend Details  

Collegium Pharmaceutical Trading Date Momentum

On October 22 2024 Collegium Pharmaceutical was traded for  36.19  at the closing time. The top price for the day was 37.40  and the lowest listed price was  36.10 . The trading volume for the day was 325.7 K. The trading history from October 22, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.74% . The overall trading delta against the current closing price is 3.98% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Collegium Pharmaceutical to competition

Other Forecasting Options for Collegium Pharmaceutical

For every potential investor in Collegium, whether a beginner or expert, Collegium Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Collegium Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Collegium. Basic forecasting techniques help filter out the noise by identifying Collegium Pharmaceutical's price trends.

Collegium Pharmaceutical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Collegium Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Collegium Pharmaceutical could also be used in its relative valuation, which is a method of valuing Collegium Pharmaceutical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Collegium Pharmaceutical Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Collegium Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Collegium Pharmaceutical's current price.

Collegium Pharmaceutical Market Strength Events

Market strength indicators help investors to evaluate how Collegium Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collegium Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Collegium Pharmaceutical stock market strength indicators, traders can identify Collegium Pharmaceutical entry and exit signals to maximize returns.

Collegium Pharmaceutical Risk Indicators

The analysis of Collegium Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Collegium Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting collegium stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Collegium Pharmaceutical to cross-verify your projections.
For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.49)
Earnings Share
2.34
Revenue Per Share
18.538
Quarterly Revenue Growth
0.165
Return On Assets
0.0968
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.